← All trials
NCT03191773
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2017
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Guangdong Pharmaceutical UniversityCollaborator
- Guangzhou Medical UniversityStudy director
- Guangzhou Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- First People's Hospital of FoshanCollaborator
- Shenzhen Institute for Innovation and Translational MedicineStudy director
- Shenzhen Institute for Innovation and Translational MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.